CIBC Private Wealth Group
IMMX icon

CIBC Private Wealth Group’s Immix Biopharma IMMX Stock Holding History

CIBC Private Wealth Group’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$209K Buy
40,000
+30,000
+300% +$123K ﹤0.01% 1168
2025
Q3 		$20.9K Buy
+10,000
New +$24K ﹤0.01% 2139

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

CIBC Private Wealth Group's IMMX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Immix Biopharma (IMMX) stake by 300% in Q4 2025, buying an estimated $123K and bringing the position to 40,000 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

CIBC Private Wealth Group first reported a position in IMMX in Q3 2025 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold IMMX as of Q4 2025.

  • CIBC Private Wealth Group held 40,000 shares of Immix Biopharma worth $209K as of Q4 2025.
  • CIBC Private Wealth Group bought 30,000 Immix Biopharma shares in Q4 2025, an estimated $123K.
  • Immix Biopharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1168 holding.
  • CIBC Private Wealth Group first reported a position in Immix Biopharma in Q3 2025 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.